Loading clinical trials...
Loading clinical trials...
The aim of the cohort prospective observational study is to define the major factors influencing the course of COVID-19 infections and its prognosis in hospitalised patients. The investigators plan to include 300 patients hospitalised with COVID-19 infection. The phone contacts with patients are due after 90 and 180 days after discharge.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital #1
Moscow, Russia
University Hospital #4
Moscow, Russia
Start Date
November 1, 2020
Primary Completion Date
March 1, 2021
Completion Date
January 10, 2023
Last Updated
January 26, 2023
345
ACTUAL participants
Chitotriosidase activity
DIAGNOSTIC_TEST
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06355232